South Korean court suspends regulator’s disciplinary action against Samsung BioLogics By Reuters

2019-01-21

© Reuters. South Korean court suspends regulator’s disciplinary action against Samsung BioLogics SEOUL (Reuters) – A South Korean court has suspended the financial regulator’s disciplinary action against Samsung (KS:) BioLogics Co Ltd (KS:) over breach of accounting rules, an official at the Seoul Administrative Court said on Tuesday. Samsung BioLogicsRead More →